Interleukin-1 reversibly inhibits the synthesis of biglycan and decorin in intact articular cartilage in culture by Hoff, J.W. Von den et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/20443
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Interleukin-1 Reversibly Inhibits the Synthesis of Biglycan and 
Decorin in Intact Articular Cartilage in Culture
HANS VON DEN HOFF, MARGRET DE KONING, JOS VAN KAMPEN, and JAN VAN DER KORST
ABSTRACT . Objective. To study the effect of interleukin-1 (IL-1) on the synthesis of proteoglycans bigiycan
(DSPG-I) and decorin (DSPG-II) in intact bovine articular cartilage.
Methods. Cartilage bearing sesamoid bones from the metacarpophalangeal joint were cultured with 
10 ng/ml IL-1 for 2 days and labelled with [35S] sulfate. One sesamoid bone from each animal had 
been labelled ex vivo. The remaining 2 were cultured with IL-1 and allowed to recover in control 
medium before labelling. Control cultures were maintained in medium without IL-1 and labelled 
concurrently with the experimental series. The dermatan sulfate proteoglycans were purified from
4 M guanidinium chloride extracts of the cartilage by gel filtration on Sepharose CL-2B and CL-4B, 
on which they appeared as a single peak. Biglycan and decorin were separated by sodium dodecyl 
sulfide polyacrylamide gel electrophoresis in high salt. Individual lanes from the gel were cut in 
slices, which were dissolved and counted for radioactivity.
Results. Ex vivo, biglycan accounted for 4% and decorin for 2% of total incorporated sulfate, IL-1 
reduced the synthesis of biglycan to 7 7 % of the level of cultured controls and that of decorin to 
73%. The synthesis of both proteoglycans returned to the control levels when the IL-1 was removed. 
IL-1 (10 ng/ml, 2 days) had no significant effect on total proteoglycan synthesis.
Conclusion. The inhibition of synthesis of biglycan and decorin by IL-1 might be important in the 
pathophysiology of cartilage destruction in rheumatic diseases. (J Rheumatol 1995;22:1520-6)
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Two types of small, nonaggregating dermatan sulfate pro­
teoglycans have been isolated from bovine articular carti­
lage1 . They are present in about the same molar amount as 
the large aggregating species2. Their core proteins, 
although similar, are distinct gene products and both have 
a molecular mass of 45 kDa3. They show 55% homology 
at the protein sequence level and have a central leucine rich 
region4. Biglycan, or DSPG-I, generally carries 2 derma­
tan sulfate chains, while decorin, or DSPG-II, carries only 
one. The g]ycosaminoglyeans (GAG) from bovine cartilage 
biglycan and decorin contain 25-29 % and 40-44% iduronate, 
respectively5. Decorin binds to collagen fibrils in the car­
tilage matrix6*7. Decorin has also been shown to inhibit col­
lagen fibril formation in vitro*. It has, therefore, been sug­
gested to be involved in the regulation of collagen fibril as­
sembly. Decorin can also bind transforming growth factor- 
ß, and thereby modulate its activity9. Biglycan is not as­
sociated with collagen in vivo , but is located in the vicinity
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RHEUMATIC DISEASES
of the chondrocyte7, Little is known about the function of 
this proteoglycan. Similar proteoglycans, with varying 
iduronate contents, have been found in the extracellular 
matrix of various other connective tissues6*7*10. They are 
also synthesized by several cell types in vitro11”13. In gen­
eral, dermatan sulfate proteoglycans seem to have a func­
tion in the regulation of cell adhesion and in intercellular 
communication14.
In inflammatory and degenerative joint diseases, the ex­
tracellular matrix of cartilage undergoes degradation15*16. 
The cytokine interleukin-1 (IL-1) has been suggested as one 
of the key mediators of cartilage destruction17*18. In rabbit 
knee joints exogenous IL-1 can induce the loss of proteogly­
cans and inhibit their synthesis19. In vitro it can induce the 
synthesis of matrix metalloproteinases20. It can also stimu­
late the synthesis of plasminogen activator, while reducing 
the production of plasminogen activator inhibitor and tissue 
inhibitor of metalloproteinases21. The expression of car­
tilage specific collagens is also inhibited by IL-122. The 
effects of IL-1 on the large aggregating proteoglycan, aggre­
can, have been extensively studied in explant cultures23-25. 
The synthesis of aggrecan and, to a lesser extent, that of the 
small proteoglycans is reduced25. Aggrecan synthesized in 
the presence of IL-1 is of the same size and has the same 
GAG composition as control aggrecan24. IL-1 also stimu­
lates the release of aggrecan from the matrix23.
To our knowledge no previous studies on the specific ef­
fects of IL-1 on biglycan and decorin in articular cartilage
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have been published. We studied the effects of IL-1 on these 
proteoglycans in cultured anatomically intact cartilage26. 
This culture system uses cartilage bearing sesamoid bones 
from bovine metacarpophalangeal (MCP) joints. Biglycan 
and decorin were separated by gel filtration and sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS- 
PAGE) in high salt1.
MATERIALS AND METHODS
MCP joints of 6-month-old calves were obtained from the Amsterdam slaugh­
terhouse. Nutrient mixture Ham F-12, Gey’s balanced salt solution/glucose 
(GBSS), and penicillin/streptomycin were from Gibco Europe (Paisley, Ren­
frewshire, UK). Human recombinant insulin-like growth factor I (IGF-I) 
was from Boehringer Mannheim GmbH (Mannheim, Germany) and hu­
man recombinant IL-1 a  was a gift from Hoffmann-La Roche (Nutley, NY, 
USA). Bovine serum albumin (BSA), fraction V globulin-free, was from 
Sigma (St. Louis, MO, USA) and sodium [35S] sulfate (400 mCi/mmol) 
from New England Nuclear (Boston, MA, USA). Instagel II liquid scintil­
lation fluid was from Packard (Downers Grove, IL, USA). The guanidini­
um chloride (GuHCl) from Sigma was pretreated with activated charcoal. 
Sepharose CL-2B, CL-4B, CL-6B, Octyl-Sepharose and most of the chem­
icals for SDS-PAGE were from Pharmacia (Uppsala, Sweden). N ,N '- 
diallyltartardiamide (DATD) was from Bio-Rad (Richmond, CA, USA) and 
prestained molecular weight markers (rainbow markers) from Amersham 
(Amersham, UK). Proteinase K type XI (Tritirachium album) was from 
Sigma, and Chondroitin AC (EC 4.2.2.5) and ABC lyase (EC 4.2.2.4) from 
ICN biomedicals (Costa Mesa, CA, USA). Endo-ß-galactosidase (Bac- 
teroides fragilis) was from Boehringer and 1,9-dimethylmethylene blue chlo­
ride (DMB) from Serva Feinbiochemica (Heidelberg, Germany). Standards 
of whale and shark chondroitin sulfate (mixed isomers) from Sigma were 
used in the DMB assay. All other chemicals were obtained from Merck 
(Darmstadt, Germany) or BDH (Poole, UK) and were of analytical grade. 
Standard preparations of decorin (fetal bovine skin) and biglycan (mature 
bovine cartilage) were kindly provided by Dr. L. Rosenberg (Montefiore 
Hospital, New York, USA).
Cartilage cultures. Both medial sesamoid bones were dissected from the 
MCP joints of each forefoot of 6-month-old calves under aseptic conditions. 
The adhering soft tissue was carefully removed26. Eight groups, each con­
sisting of the 4 sesamoid bones from a single animal, were obtained in this 
way. Cartilage from the sesamoid bones of any individual calf is uniform 
with respect to GAG synthesis, GAG content, and proteoglycan 
composition27. The groups were paired and each pair was cultured and 
processed simultaneously, one as a control and the other as an experimen­
tal series. The sesamoid bones were cultured in either 20 ml control medi­
um or 20 ml control medium supplemented with 10 ng/ml IL-1. The con­
trol medium consisted of Ham F-12 containing 500 ^M S04, 0.1 % penicil­
lin/streptomycin, 0,1 % BSA, and 5 ng/m! IGF-I. The sesamoid bones were 
incubated in 50 ml polypropylene tubes at 37°C in a humidified atmosphere 
of 5% C 02 in air26. Media were changed every other day. The cultures 
were labelled for 17 h with 40 fiCilml of 35S04 in the appropriate medi­
um. Less than 1% of the macromolecular 35S04 is released into the cul­
ture medium during labelling. The sesamoid bones were then washed in 
cold GBSS at 4°C, and the cartilage was removed in 1-2 mm2 pieces and 
washed again 3 times in cold GBSS at 4°C. This procedure reduced the 
amount of free label in the cartilage to less than 1 % of that of total incorpo­
rated label. The first sesamoid bone from every series was labelled ex vivo 
in control medium. The second bone of an experimental series was cul­
tured with 10 ng/ml IL-1 for 2 days and labelled. The 2 remaining sesa­
moid bones were also cultured with IL-1 for 2 days, but were then changed 
to control medium and labelled at Days 4 and 9. The sesamoid bones from 
a control series were cultured in control medium for up to 9 days and labelled 
concurrently.
Extraction and gel filtration. The cartilage samples were cut into 20 fxm
slices in a cryostat. The slices were lyophilized, weighed, and extracted 
for 60 h at 4°C in 4 M GuHCl/potassium acetate buffer (pH 5.8) in the 
presence of proteinase inhibitors. The buffer contained 10 mM EDTA, 5 
mM benzamidine HC1, 100 mM 6-aminocaproic acid, 10 mM PMSF, and
5 mM N-ethylmaleimide. The residue was dissolved in 0.5 M NaOH at 
60°C. Typical extraction percentages were 95% for total GAG and 85% 
for labelled GAG. Extracts were applied to Sepharose CL-2B columns (1 
X 196 cm) and eluted at 3.0 ml/h with a dissociative buffer of pH 6.1, 
which contained 4 M GuHCl, 0.1 M sodium sulfate, and 0.05 M sodium 
acetate. Samples derived from the same calf were run on the same column. 
The fractions (2 ml each) containing the small proteoglycans were pooled, 
concentrated, and applied to a Sepharose CL-4B column (0.66 x 140 cm). 
The flow rate was 2.7 ml/h and 0.7 ml fractions were collected. The GAG 
content of the fractions was determined by the DMB method28 and their 
radioactivity by liquid scintillation counting. The recovery from both 
Sepharose CL-2B and CL-4B was more than 98%. The purified samples 
were concentrated, precipitated with ethanol, and dried.
Analysis o f GAG. In a separate experiment the small proteoglycans were 
pooled after Sepharose CL-2B chromatography and then digested with pro­
teinase K. The proteinase was inactivated for 10 min at 95 °C, and GAG 
were sequentially digested with 0.5 U/ml of chondroitin AC lyase, of chon­
droitin ABC lyase* and of endo-ß-galactosidase, each for 18 h at 37°C. 
After each step a sample of the digest was applied to a Sepharose CL-6B 
column. The decrease of the peak area of the GAG on CL-6B was used 
to estimate the extent of digestion. Sequential digestion showed that GAG 
of the peak of labelled small proteoglycans on Sepharose CL-2B contained 
74% D-glucuronic acid residues, 11% L-iduronic acid residues, and 16% 
keratan sulfate. The presence of a large amount of keratan sulfate indicated 
that this peak still contained some large proteoglycans and possibly 
fibromodulin. The samples from Sepharose CL-2B were, therefore, rerun 
on Sepharose CL-4B.
SDS-PAGE. The material from Sepharose CL-4B was dissolved in sample 
buffer containing 0.08 M Tris/HCl, 1% SDS, 0.01% bromophenol blue, 
16% glycerol, 6 M urea and 5% ß-mercaptoethanol, pH 6 .8, Rainbow 
markers were diluted 1:1 in sample buffer. The samples were heated to 
60°C for 2 h and applied to a 4-15% acrylamide/DATD gel in 0.375 M 
Tris with a 3,3% stacking gel1,29, The 8 samples from an experimental 
series and its control series were analyzed on the same gel. The gels (12 
X 14 X 0.3 cm) were run at 20 mA overnight in electrophoresis buffer 
containing 0.05 M Tris/HCl, 0.38 M glycine, 0.1% SDS, and 0.007% ß- 
mercaptoethanol, pH 8.4. After fixation, the gels were stained with alcian 
blue30, destained, and scanned with an LKB laser scanner. Individual lanes 
were cut from the gel, frozen in dry ice, and sliced with a Mickle gel slicer. 
The slices (1 mm) were dissolved in 250 /d 2 % periodic acid at 60°C and 
counted for radioactivity in Instagel. Chondroitin sulfate standards were 
also run on a gel and scanned. The amount of small proteoglycans in the 
samples was determined after integration of the scans. The apparent molecu­
lar mass of biglycan and decorin was estimated from linear plots of the 
logarithm of the molecular mass of protein standards against their relative 
mobility (Rf) in the gel.
Hydrophobic interaction chromatography. Some purified samples from 
Sepharose CL-4B were also run on an Octyl-Sepharose column (0.7 x  4 
cm) as described5, to verify the separation of biglycan and decorin in gel 
electrophoresis. The samples were applied in 4 M GuHCl, 0.15 M sodium 
acetate, pH 6.3, and allowed to bind for 2 h. The column was washed with
3 volumes of the same buffer, and the samples were eluted with a gradient 
of 0-1% CHAPS. Comparison of the 2 separation methods showed that 
less than 7 % of the biglycan migrated to the lower (decorin) band in gel 
electrophoresis.
Calculations. The total GAG synthesis rate was determined from the total 
amount of macromolecular [35S1 sulfate in the 4 M GuHCl extract and the 
NaOH digest of the residue.
The synthesis of biglycan and decorin was calculated from the total GAG 
synthesis rate, the amount pooled on Sepharose CL-2B and CL-4B, and
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the radioactivity associated with the peaks on the gel. The significance of 
differences between group means was calculated by 2-way analysis of var­
iance and the analysis of simple effects. All results are expressed as mean 
±  SEM with N =  4 unless stated otherwise.
RESULTS
Effect o f  IL-1 on total G AG  synthesis and content. Four car­
tilage bearing sesamoid bones from the same animal were 
cultured for 1, 2, 4, and 9 days and labelled with [35S] sul­
fate. The average ex vivo (Day 1) GAG synthesis rate was 
1.95 ±  0.15 nmol S 0 4/m g dw/day (N =  8). The GAG 
synthesis rates on the following days were expressed as per­
centages of the individual ex vivo rates to compensate for 
the variation between animals (Figure 1). The GAG synthe­
sis rate of the controls was found to have dropped to 61.6 ±  
7.2% of the ex vivo rate, on Day 2, after which it increased. 
The decrease probably represents the adaptation to the cul­
ture conditions. In the experimental series, an IL-1 concen­
tration of 10 ng/ml (for 2 days) was chosen because it does
Q LJ_________ IÛ2X______\:Z /A__  V //S
1 2  4 9
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Fig. 1, The effect of IL-1 on total GAG synthesis and total GAG content 
of intact cartilage. The 4 sesamoid bones from each calf were cultured for
1, 2, 4 and 9 days, and labelled with [35S] sulfate. One sesamoid bone was 
labelled ex vivo (Day 1) in control medium. The other 3 were maintained 
in medium with 10 ng/ml IL-1 during the first 2 days of the culture period 
(hatched bars). Control series were maintained in medium without IL-1 (open 
bars). GAG synthesis (a) and content (b) are shown as percentage of the 
ex vivo level. The significance of differences between group means was 
tested by 2-way ANOVA and the analysis of simple effects. No differences 
between experimental groups and control groups were significant.
not enhance proteoglycan degradation in this culture system. 
IL-1 reduced the synthesis rate to 48.2 ±  5.1 % by Day 2, 
but the difference with the control was not significant. This 
slight difference persisted to Days 4 and 9. Figure lb  shows 
the total GAG content of the cartilage during culture. The 
average ex vivo GAG content was 171.5 ±  4.8 /ig GAG/mg 
dw (N =  8). No significant changes in GAG content occurred 
during the culture period.
Purification o f  the dermatan sulfate proteoglycans. Cartilage 
samples from the above experiments were extracted with 4 
M GuHCl, and the extracts run on Sepharose CL-2B columns 
(Figure 2). The proteoglycans eluted in 2 separate peaks, 
one with a Kav of 0.3 and one with a Kav of 0.7. The first 
peak represents the large aggregating proteoglycan (aggre­
can); the second peak, smaller proteoglycans. Sequential 
digestions showed that the latter was enriched in dermatan 
sulfate. The peak containing the dermatan sulfate proteogly­
cans, was pooled as indicated, concentrated, and applied to 
a Sepharose CL-4B column for further purification (Figure 
3). The small proteoglycans eluted as a single peak at Kav
0.45, with the labelled molecules slightly larger than the non­
labelled molecules. A considerable amount of mainly non­
labelled aggrecan eluted in front of the small proteoglycans. 
The small proteoglycans were pooled in such a way that all 
labelled molecules were included. This pool was prepared 
for electrophoresis and run on an SDS-polyaery 1 amide gra­
dient gel.
SDS-PAGE . In Figure 4 a typical gel profile of a purified 
sample is compared with profiles of biglycan and decorin 
standards. The Rf values of the nonlabelled standards were
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Fig. 2. Sepharose CL-2B chromatography of cartilage extracts. Cartilage 
samples were extracted with 4 M GuHCl. The extracts were run on Sepharose
CL-2B columns. Radioactivity (--------- ) and chondroitin sulfate (CS) (------ )
was measured in the fractions. The elution pattern of proteoglycans from 
an ex vivo sample is shown. The small proteoglycans were pooled as indicated 
by the vertical lines. Void volume and total volume are indicated by the 
arrows.
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Fig. 3. Sepharose CL-4B chromatography of small proteoglycans. The smali 
proteoglycans pooled from Sepharose CL-2B (Figure 2) were concentrated
and run on Sepharose CL-4B columns, Radioactivity (-------—) and
chondroitin sulfate (CS) (-------) was measured in the fractions. The small
proteoglycans were pooled as indicated by the vertical lines. Void volume 
and total volume are indicated by the arrows.
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Fig. 4. SDS-PAGE of a purified sample and biglycan/decorin standards. 
The small proteoglycans pooled from Sepharose CL-4B (Figure 3) were 
run on a 4-15% polyacrylamide gradient gel in 0.375 M Tris (a). Separate
lanes were scanned at 633 nm (--------- ) and sliced. The radioactivity of
the slices was determined using scintillation counting ( • ------• ) .  The profiles
of standard preparations of biglycan (mature bovine cartilage) and decorin 
(fetal bovine skin) are also shown (b). The position of molecular weight 
markers (kDa) is indicated by the arrows.
0.32 (biglycan) and 0.46 (decorin) (Figure 4b). The mobili­
ties of nonlabelled biglycan and decorin in the purified 
samples were similar, 0.30 and 0,48, respectively (Figure 
4a). Less than 7% of the biglycan migrated to the lower 
(decorin) band as determined by hydrophobic interaction 
chromatography. The profile shows that the sample was still 
contaminated by some larger proteoglycans. The labelled 
biglycan and decorin in the samples were larger than the non- 
labelled species, with Rf values of 0.25 and 0.43. The esti­
mated apparent molecular masses o f labelled biglycan and 
decorin in the samples were 320 kDa and 150 kDa, respec­
tively. The apparent molecular masses of nonlabelled bigly­
can and decorin were less: 250 kDa and 120 kDa, respec­
tively. The mass of the 2 species remained the same through­
out the culture period.
Effect o f  IL-1 on the synthesis o f  biglycan and decorin . Gel 
profiles of labelled small proteoglycans of a typical series 
of samples are shown in Figure 5. Only the upper 75% of 
the gel is shown (Rf =  0-0 .75). Smaller 35S-labelled 
molecules were not detected in the lower part of the gel. The 
ex vivo profiles o f samples from all the different animals were 
similar (Figure 5a), The synthesis o f both biglycan and deco­
rin in the controls decreased in culture. Treatment with IL-1 
reduced the synthesis of both proteoglycans to below the cor­
responding levels in the controls (Figure 5b). Two days after
t
the cytokine was removed the synthesis of both proteogly­
cans was still reduced (Figure 5c). By the 7th day of 
recovery, the synthesis of biglycan and decorin had returned 
to control levels (Figure 5d).
Synthesis rates of biglycan and decorin were calculated 
from total synthesis rates (Figure i), pooled fractions after 
gel filtration (Figures 2 and 3) and radioactivity in the respec­
tive peaks (Figure 5). The ex vivo  synthesis rates of bigly­
can and decorin were 0.075 ±  0.007 and 0.039 ±  0.004 
nmol S 0 4/mg dw/day (N =  8). Biglycan and decorin thus 
accounted for 4 and 2% of the total ex vivo synthesis rate. 
The synthesis rates for the following days are given as per­
centages of the individual ex vivo value (Figure 6 ). This was 
done to compensate for the variation in ex vivo synthesis rates 
among the samples from different animals. The synthesis of 
biglycan in control cultures decreased with time (Figure 6a). 
On Day 2, the synthesis rate o f  biglycan was. 83.5 ±  5.0%  
of the ex vivo rate. After culture with IL-1, the biglycan syn­
thesis rate was significantly lower than that in the control; 
64.1 ±  7.4% (p <0.01). The difference between control and 
IL-1 treated samples persisted to Day 4, but by Day 9 the 
synthesis o f biglycan had returned to control levels. The syn­
thesis of decorin followed much the same course (Figure 6b). 
In control cultures the synthesis of decorin decreased to 73.2 
±  2.7% of the ex vivo synthesis rate. Culturing with IL-1 
reduced decorin synthesis to 53.4 ±  3.0% by Day 2 (p 
< 0 .01). This difference also persisted to Day 4 but by Day 
9 the synthesis of decorin had also returned to control levels. 
The amount of nonlabelled biglycan and decorin in the gels
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Fig. 5. SDS-PAGE of purified samples from an experimental series and 
a control series. Samples from cartilage labelled on Day 1 (a), 2 (b), 4 (c), 
and 9 (d) were extracted, purified and analyzed on SDS-polyacrylamide 
gels. The profiles of experimental samples ( • • • • • )  and corresponding
controls (------- —) are shown. Only the upper 75% of the gels is shown.
The vertical lines indicate the peak areas for biglycan (B) and decorin (D).
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Fig, 6, The cffect of IL-1 on the synthesis of biglycan and decorin. The 
areas of the peaks of biglycan and decorin on gel (Figure 5) were used to 
calculate their respective synthesis rates (see Materials and Methods). The 
results are shown as percentage of the Day 1 level for control (hatched bars) 
and experimental series (open bars). Panel a shows the synthesis of biglycan; 
Panel b, that of decorin. The significance of differences between group means 
was tested by 2-way ANOVA and the analysis of simple effects. Significant 
differences between treated groups and the corresponding controls are 
indicated by the asterisks (** =  p < 0 .01).
was determined using standards of chondroitin sulfate. The 
amounts of small proteoglycans in the cartilage were 11.0 
± 0 .4  and 3.7 ±  0.1 G AG/mg dw for biglycan and deco­
rin, respectively (mean ±  SEM, N =  32). No significant 
changes were observed during culture.
DISCUSSION
The separation of biglycan and decorin by SDS-PAGE at high 
ionic strength is thought to occur through the self-association 
of biglycan1. However, biglycan can occur with one instead 
of 2 dermatan sulfate chains, and this might interfere with 
its self-association3. We therefore verified the separation of 
some samples by hydrophobic interaction chromatography, 
which depends on the properties of the core protein5. The 
apparent molecular masses that we found for nonlabelled 
biglycan and decorin correlate well with those obtained by
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others working with immature bovine cartilage5. Biglycan 
and decorin from mature bovine cartilage are smaller1. 
Similar changes, caused by a decrease in GAG chain length, 
occur in human articular cartilage31. The labelled biglycan 
and decorin in our samples were larger than the nonlabelled 
species, a phenomenon also observed in.samples from hu­
man cartilage31. It is probably caused by the synthesis of 
longer GAG chains in culture32.
The synthesis of both biglycan and decorin in the controls 
decreased during culture. This extends our previous results, 
which show that there is a decrease in the synthesis of small 
proteoglycans in bovine articular cartilage during culture33. 
It is possible to restore their synthesis by loading the 
cartilage34. The decrease seems, then, to be related to the 
absence of stress on the cartilage during normal culture. Our 
present results show that incubation with IL-1 reduced the 
synthesis of both biglycan and decorin to below the cor­
responding levels in cultured controls. The synthesis of both 
species returned to control levels following the removal of 
cytokine. The regulation of synthesis of dermatan sulfate pro­
teoglycans has also been studied in other systems. IL-1 in­
creases considerably the mRNA level of the dermatan sul­
fate proteoglycan in fibroblasts although the synthesis is only 
slightly enhanced35*36. In cultures of bovine chondrocytes 
retinoic acid inhibited the synthesis of biglycan, while decorin 
synthesis underwent a 12 to 18-fold increase11. The mRNA 
levels underwent similar changes. In fibroblast cultures trans­
forming growth factor-ß increased the expression of bigly­
can w hile that o f decorin  rem ained relatively 
unaffected12’36"38. These reports demonstrate that there is a 
difference in the regulation of biglycan synthesis and that 
of decorin synthesis. Our results show that, in intact articu­
lar cartilage, the regulation of synthesis of biglycan and deco­
rin by IL-1 is similar.
After 2 days of culture with IL-1, the total amount of GAG 
in the matrix was unchanged, and there were no changes in 
biglycan and decorin content. In cultures of explanted car­
tilage a considerable loss of proteoglycans occurs within 3 
days23. Continuous infusion of IL-1 in rabbit knee joints for 
14 days resulted in a 50% reduction in the amount of intact 
decorin core protein39. Both decreased biosynthesis and en­
hanced degradation contribute to the depletion of small pro­
teoglycans in articular cartilage in response to IL-1.
Decorin is thought to be involved in the regulation of col­
lagen fibril assembly, and .in the stabilization of the colla­
gen network. The inhibition of synthesis of decorin by IL-1 
might, therefore, be an important process in the pathophysiol­
ogy of cartilage destruction in rheumatic diseases. A further 
function of the small proteoglycans might lie in the regula­
tion of growth factor activity. A reduction in the content of 
these proteoglycans might disturb the balance of growth fac­
tors in diseased tissue. Biglycan probably has other special­
ized functions because its localization and regulation of syn­
thesis seem to be different.
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